Search

everythinglearnresearchcommunity

for

Search:↓

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Reducing gefitinib dosage improved hair loss, but scarring remained.

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

Misdiagnosis led to unnecessary treatment due to a genetic mutation affecting thyroid hormone resistance.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

The horse had a rare disease causing weight loss and skin issues, leading to euthanasia due to poor treatment options.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

AH-001 could be a safer and more effective treatment for hair loss.

Understanding EGFR roles could lead to new hair loss treatments.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Tissue-engineered skin substitutes can model junctional epidermolysis bullosa and may help develop gene therapy.

Tiny lipid particles loaded with a hormone gather in hair follicles, which may help treat hair loss.

A young boy with Netherton syndrome improved significantly using IVIG, dupilumab, and dietary changes.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

Blocking certain immune signals can reduce skin damage from radiation therapy.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.

Enzyme replacement therapy may help alleviate symptoms in complex cases like this.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Epidermal growth factor helps skin and hair regeneration but needs more research for better understanding.

Pre-existing skin conditions and drug reactions are the main causes of exfoliative erythroderma.

The hydrogel effectively treats dental implant issues by killing bacteria, reducing inflammation, and improving implant success.